NHLBI Strategic Visioning Process: Charting Our Future Together

Slides:



Advertisements
Similar presentations
Board of Early Education and Care Strategic Planning Update February 10, 2009.
Advertisements

Comparative Emergency Management
Retreat Topics iPSC Opportunities in NIAMS Diseases Science Management Forum: Leveraging and Strategic Funding Collaborations Atopic Dermatitis Advancing.
(The Global Programme of Research On Climate Change Vulnerability, Impacts and Adaptation) Adaptation Knowledge Day V: Climate Change Adaptation Gaps BONN,
Advanced Health Models and Meaningful Use Workgroup: Roadmap Charge Overview Paul Tang, chair Joe Kimura, co-chair.
Funding Opportunities at NSF Jane Silverthorne International Arabidopsis Consortium Workshop January 15, 2011.
Wrapup. NHGRI strategic plan What does the NIH think genomics should be for the next 10 years? [Nature, Feb. 2011]
Introduction to Ludwig Center at Harvard Cancer Research Collaborative Joan Brugge, PhD George Demetri, MD.
BELMONT FORUM E-INFRASTRUCTURES AND DATA MANAGEMENT PROJECT Updates and Next Steps to Deliver the final Community Strategy and Implementation Plan Maria.
Draft – discussion only Advanced Health Models and Meaningful Use Workgroup: Update Paul Tang, chair Joe Kimura, co-chair March 10, 2015.
Office of Academic Affairs June 1, 2007 Academic Priorities: Next Steps Spring Symposium 2007.
Center for Biologics Evaluation and Research Applying Regulatory Science to Advance Development of Innovative, Safe and Effective Biologic Products Carolyn.
Center for Biologics Evaluation and Research FDA Overview Site Visit Carolyn A. Wilson, Ph.D. Associate Director for Research.
Challenge Questions How good is our operational management?
Presentation on CCELP. For more information: Presented to Bay Area Funders By: Members of.
Aligning Efforts— Statewide Commission Pat Simmons, MS, RD, LD Missouri Department of Health and Senior Services.
Developing a Policy Framework for Assessing and Recognizing Prior Learning Key Issues for Consideration.
The NIH Roadmap for Medical Research
Purpose: Serves as guide to accelerate research to reduce the prevalence and burden of obesity, so that people can look forward to healthier lives Enhances.
2011 SIGnetwork Regional Meetings Guidance in Structuring a Communities of Practice.
Healthy People 2020: Charting the Course to a Healthier Nation Penelope Slade-Sawyer, P.T., M.S.W. RADM, USPHS Deputy Assistant Secretary for Health (Disease.
NIH Implementation of ARRA. NIH is grateful to President Obama and Congress for the opportunity for NIH to play its part in improving the Nation’s health.
Enterprise IT Decision Making
“Critical Path” for Food and Nutrition Science Board November 5, 2004 Alan M. Rulis.
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
Strategic Plan Evidence, knowledge and action for a healthier Ontario October 2, 2013 Presentation to ANDSOOHA.
GEO Work Plan Symposium 2012 ID-05 Resource Mobilization for Capacity Building (individual, institutional & infrastructure)
Children’s Mental Health Access & Treatment Services presented to Province-wide Health Advisory Council Saturday, October 13, 2012.
NIH Roadmap for Medical Research and Common Fund Update on Recent Changes Dinah Singer, Ph.D. Director, Division of Cancer Biology June 18, 2008.
Canadian Institutes of Health Research New Open Suite of Programs and Peer Review Enhancements University of Manitoba February 14, 2012.
AN INVITATION TO LEAD: United Way Partnerships Discussion of a New Way to Work Together. October 2012.
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Open Forum Educational Master Plan (EMP) Toyon Room June 4, 2015 E. Kuo FH IR&P.
1 Implementation of the National Academies’ Program Recommendations: NIOSH PPT Program Maryann D’Alessandro, Ph.D. Associate Director for Science, NPPTL.
National Science Foundation 1 Evaluating the EHR Portfolio Judith A. Ramaley Assistant Director Education and Human Resources.
Precision Medicine A New Initiative. The Concept of Precision Medicine (PM) The prevention and treatment strategies that take individual variability into.
1 Mid-Term Review of the Hyogo Framework for Action Roadmap to Disaster Risk Reduction in the Americas & HFA Mid-Term Review.
NIH Activities Related to Big Data Jerry Sheehan Assistant Director for Policy Development National Library of Medicine Board on Research Data and Information.
1 Investing in America’s Future The National Science Foundation Strategic Plan for FY Advisory Committee for Cyberinfrastructure 10/31/06 Craig.
Promoting Diversity at the Graduate Level in Mathematics: A National Forum MSRI October 16, 2008 Deborah Lockhart Executive Officer, Division of Mathematical.
CPTR Overview CPTR 2012 Workshop October 2-4, 2012.
ESIP Federation Air Quality Cluster Partner Agencies.
Characterization, Inventory and Monitoring of trends in indigenous livestock Dr. E. D. Ilatsia D. N. Kamiti 23-Oct-15Animal Breeding and Genomics Group1.
Building Partnerships to Enhance the Colorado Nursing Workforce.
NAS/IOM Review of Rare Diseases Research and Orphan Products Development - USA Timothy Cote, M.D., MPH Director, Office of Orphan Products Development.
Maternal Health Task Force POPPHI Working Group Meeting, Washington DC, April 6, 2009.
The Importance of a Strategic Plan to Eliminate Health Disparities 2008 eHealth Conference June 9, 2008 Yvonne T. Maddox, PhD Deputy Director Eunice Kennedy.
SMRB Working Group on Approaches to Assess the Value of Biomedical Research Supported by NIH SMRB Working Group on Approaches to Assess the Value of Biomedical.
Developing a Framework In Support of a Community of Practice in ABI Jason Newberry, Research Director Tanya Darisi, Senior Researcher
TRANSPORTATION RESEARCH BOARD WATER SCIENCE AND TECHNOLOGY BOARD TRANSPORTATION RESEARCH BOARD TRB’s Vision for Transportation Research.
1 Investing in America’s Future The National Science Foundation Strategic Plan for FY OPP Advisory Committee 10/26/06.
Applied Sciences Perspective Lawrence Friedl, Program Director NASA Earth Science Applied Sciences Program LANCE User Working Group Meeting  September.
MD2K is an NIH Big Data to Knowledge (BD2K) Center of Excellence. Visit MD2K: Center of Excellence for Mobile Sensor Data-to-Knowledge.
NIH and the Clinical Research Enterprise Third Annual Medical Research Summit March 6, 2003 Mary S. McCabe National Institute of Health.
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Creating an Interoperable Learning Health System for a Healthy Nation Jon White, M.D. Acting Deputy National Coordinator Office of the National Coordinator.
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
Future Directions for NIH Research in the Behavioral and Social Sciences Raynard S. Kington, MD, PhD Associate Director for Behavioral and Social Sciences.
BID Initiative Learning Network (BLN) Update for BLN Discussion Meeting Arusha, Tanzania, 8 th December, 2015.
Archived File The file below has been archived for historical reference purposes only. The content and links are no longer maintained and may be outdated.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
Accelerating Progress Towards a More Diverse and Inclusive Harvard Chan School April 17, 2015.
+ Welcome to PAHO/WHO Sustainable Development and Health Toolkit for the UN Global Conference RIO + 20 Welcome to PAHO/WHO Sustainable Development and.
Board of Early Education and Care Strategic Planning Update October 14, 2008.
David M. Murray, Ph.D. Associate Director for Prevention Director, Office of Disease Prevention Multilevel Intervention Research Methodology September.
Science for Global Health: Fostering International Research Collaboration James Herrington, PhD, MPH Director Division of International Relations Fogarty.
Update from the Faster Payments Task Force
HHS STRATEGIC PLAN FY 2018 – 2022 AN OVERVIEW
HHS Strategic plan fy An Overview
The Digital Library for Earth System Education (DLESE):
Presentation transcript:

NHLBI Strategic Visioning Process: Charting Our Future Together Dr. Lenora Johnson Director Office of Science Policy, Engagement, Education, and Communications February 11, 2015 NHLBI’s Strategic Visioning process is designed to engage the entire NHLBI community in identifying the most Compelling Questions and Critical Challenges in heart, lung, blood, and sleep  research. We want to ensure that our partners help determine NHLBI’s future direction, and we welcome your participation in an ongoing process that will inform our priority setting, decision making, and resource allocation.

NHLBI Strategic Visioning Process: Charting Our Future Together Dr. Stephen C. Mockrin Director Division of Extramural Research Activities Dr. James Kiley Director Division of Lung Diseases February 11, 2015

Objectives for Today’s Webinar Strategic Visioning Process -- Overview How to contribute to the Strategic Visioning Process Strategic Goal Areas Compelling Questions (CQs) and Critical Challenges (CCs) Strategic Visioning Forum There are two major objectives for this presentation the 1st is to describe the overall strategic visioning process and the second is to describe your participation – in terms of when you can participate where you can participate how you can contribute   The three key elements of the Strategic Visioning Process are the strategic goal areas the Compelling Questions and the Critical Challenges There are four strategic goal areas and within each of these strategic goals there will be a number of compelling questions and critical challenges.

Strategic Visioning Process – Overview and Community Input Timeline Fall 2014 Early 2016 Fall 2014 Winter 2015 Spring 2015 Summer 2015 Summer 2015 Fall 2015 Early 2016 NHLBI Synthesizes Input and Releases Draft Strategic Visioning Scientific Priorities NHLBI and Advisory Groups Plan Strategic Visioning Framework NHLBI Releases Strategic Visioning Framework NHLBI Community Submits CQs and CCs NHLBI Community Provides Input NHLBI and Advisory Groups Refine Scientific Priorities NHLBI Releases Strategic Visioning Scientific Priorities This figure summarizes the SV process, starting from the Fall of 2014 on the left and proceeding to early 2016 on the far right. In terms of timing, we have divided the process into 7 stages (shown as boxes) and labeled them by seasons. You will notice two highlighted boxes – Spring 2016 and Summer 2016 – which are the stages you can provide input. In stage 1 – the Fall of 2014 -- we solicited ideas from the National Heart, Lung, and Blood Advisory Council, the NHLBI Board of Extramural Experts, and the NHLBI staff. This process informed the development of a Framework that details why and how we would like to solicit community input and includes examples of Questions and Challenges. In stage 2 – Winter 2015 – we will launch a Strategic Visioning website, make the Strategic Visioning Framework available, and begin the public input process.   In stage 3 – Spring 2015 -- The NHLBI community contributes Questions and Challenges. There will be multiple channels for input, including email, regular mail, and a platform called the Strategic Visioning Forum. All modes will allow contributors to submit new Questions and Challenges. The Strategic Visioning Forum will also allow participants to comment and vote on Questions and Challenges that were already contributed. In stage 4 -- Summer 2015 – The submissions will be reviewed and synthesized, and a Draft NHLBI Strategic Vision Scientific Priorities document will be released for public comment. In stage 5 – also in the Summer 2015 – The public will comment on the Draft Strategic Vision Scientific Priorities document. In stage 6 – Fall 2015 -- the NHLBI, working with its scientific advisory groups, will select a final prioritized list of Questions and Challenges. In stage 7 -- Early 2016 -- The final Strategic Vision Scientific Priorities document will be published and disseminated. Spring 2015 Compelling Questions and Critical Challenges Submitted for NHLBI Consideration Summer 2015 Public Comment on Draft Strategic Visioning Scientific Priorities

Strategic Visioning Goal Areas Goal 1: Promote Human Health To expand knowledge of the molecular and physiological mechanisms governing the normal function of heart, lung, blood, and sleep systems as essential elements for sustaining human health. Goal 2: Reduce Human Disease To extend our knowledge of the pathobiology of heart, lung, blood, and sleep disorders and enable clinical investigations that advance the prediction, prevention, preemption, treatment, and cures of human disease. Goal 3: Advance Translational Research To facilitate innovation and accelerate research translation, knowledge dissemination, and implementation science that enhances public health. Goal 4: Develop Workforce and Resources To enable and develop a diverse biomedical workforce equipped with the essential research resources to pursue emerging opportunities in science.  Goal 1: is to expand knowledge of the molecular and physiological mechanisms governing the normal function of heart, lung, blood, and sleep systems as essential elements for sustaining human health. This goal addresses the intrinsic value of an in-depth understanding of normal biology and physiology as essential to sustaining and enhancing human health. The intent of this goal is to explore normal human physiology at all levels, spanning the molecular, cellular, individual, and population levels. It encompasses basic, preclinical, and clinical research.   Goal 2: is to extend our knowledge of the pathobiology of heart, lung, blood, and sleep disorders and enable clinical investigations that advance the prediction, prevention, preemption, treatment, and cures of human disease. It focuses on elucidating the fundamental mechanisms and molecular pathways of disease to enable interventions. This goal may span basic, preclinical, and clinical research, including clinical trials. Goal 3: is to facilitate innovation and accelerate research translation, knowledge dissemination, and implementation science that enhances public health. Goal 3 aims to facilitate and accelerate activities that promote the progression of research findings and technologies from the bench into clinical practice. It encompasses translation across the entire research spectrum (sometimes characterized as T0-T4), bridging basic to clinical, clinic to practice, and population to public health impact. Goal 4: is to enable and develop a diverse biomedical workforce equipped with the essential research resources to pursue emerging opportunities in science. It focuses on enabling the biomedical workforce to fully capitalize on emerging scientific opportunities: (1) by equipping today’s workforce with new skills and the necessary tools and resources; and (2) by cultivating a diverse next generation trained in cutting-edge science and the requisite multi-disciplinary skills. This goal spans all phases of research including basic, clinical, translational, and population studies.

Overview of Compelling Questions (CQs) and Critical Challenges (CCs)

What is a Compelling Question? What is a Critical Challenge? Strategic Visioning Process Objective: Develop Compelling Questions and Critical Challenges Objective: Develop compelling questions (CQs) and critical challenges (CCs) to guide the Institute’s priorities, decision-making, and resource allocation over the next decade. What is a Compelling Question? A Compelling Question: Probes a specific line of inquiry Identifies a crucial knowledge gap or opportunity Transcends an individual investigator- initiated program Requires NHLBI facilitation Is feasible within the next decade What is a Critical Challenge? A Critical Challenge: Is a barrier or an impediment that hinders scientific progress Overcoming a critical challenge: Requires enabling tools, infrastructure or resources Will result in significant impact Is feasible to overcome within the next decade For each Strategic Goal, we will collectively identify compelling questions and critical challenges which, if answered or overcome, will significantly advance HLBS research. A compelling question is intended to probe a specific line of inquiry, identifies a crucial scientific knowledge gap, transcends an individual investigator-initiated program, requires NHLBI’s facilitation in order to be answered, and is feasible within the next decade. A critical challenge, on the other hand, is a barrier to an unexplored area or an impediment that hinders scientific progress. Critical challenges will generally identify needed resources, infrastructure, or tools that could catalyze major scientific advances if they are overcome.

Illustrative CQs and CCs Jim and Steve Present Notes: Transition Slide

Goal 1: Promote Human Health - To expand knowledge of the molecular and physiological mechanisms governing the normal function of heart, lung, blood, and sleep systems as essential elements for sustaining human health. Illustrative Compelling Question   Compelling Question 1.1: What are the “protective” genetic variants that are associated with a resilient, healthy phenotype or that mediate an intrinsic “resistance” to the influence of risk factors that accelerate HLBS diseases throughout the human lifespan? Illustrative Critical Challenge   Critical Challenge 1.1: There is a need for the NHLBI to catalyze the development of tools and shared data resources – the “Heart, Lung, and Blood Systems Biology Connectome” – that facilitates the systematic characterization of the dynamic changes in complex molecular interactions that sustain normal HLB system functions under various physiological conditions. This open resource would comprehensively catalogue these genomic, epigenomic, and metabolic pathways, as well as provide tools to systematically probe them. Examples are for Goal 1 The examples are just examples and do not indicate any institute priorities. More Illustrative examples can be found on the Strategic Visioning Website In addition to your question, you will also be asked to submit some additional information about compelling question or critical challenge. Feasibility Impact

Gathering Community Feedback Strategic Visioning Forum for Submission of CQs and CCs

Strategic Visioning Forum Strategic Visioning Forum, a digital crowdsourcing tool, allows us to gain the broadest input possible. Benefits of crowdsourcing Generate innovative ideas Get ideas from new and diverse sources Engagement of participants NHLBI Strategic Visioning Website Strategic Visioning Forum The Strategic Visioning Forum will be a tool used to facilitate the ideation process in order to solicit internal stakeholder feedback.

Visit the Strategic Visioning Forum

Facebook: www.facebook.com/NHLBI Questions? Follow Us on Twitter: @nih_nhlbi and Facebook: www.facebook.com/NHLBI For Launch Updates